Isioma Egbuniwe MBBS PhD FRCPath

Cholangiocarcinoma + Immunology research @UoN_BDI| Histopathology doc @nottmhospitals| Wife + mommy| Views my own 🇳🇬🇬🇧

[Una Rastović @UnaRastovic]

Thank you all for your support and for taking a moment to vote! 😊
@DrElePalma @ChokshiLab @UrbaniLab

[Becki Lee @BeckiLee]

Our PhD is part of the black leaders programme so please do reach out if you are interested in melanoma

[Helen Morement @HelenMorement]

All of us at #AMMF welcome this news from #NICE - a long overdue improvement in first-line treatment for those with #cholangiocarcinoma or gallbladder cancer>
#bileductcancer #livertwitter

[ccauk @ccaukgroup]

Abstract submission and registration now open for the CCA-UK National Meeting on 2nd Feb 2024.
Further information, including a draft programme can be found here -https://t.co/pjOkSYFE2f…

#cholangiocarcinoma #bileductcancer #CCAUK2024

[Cancer Research UK @CR_UK]

The immunotherapy drug durvalumab is now recommended as a first option for treating advanced biliary tract cancers in England and Scotland. In England alone, over 700 people will soon be eligible to receive the treatment. It's likely the decision will also be adopted in Wales and Northern Ireland. Find out more information here 👉https://t.co/WO1XHEKufM

[AMMF @CharityAMMF]

Less than 6 months to go until AMMF’s Hybrid 2024 European Cholangiocarcinoma Conference! Watch out for registration opening soon. https://t.co/oZd5CJnHPb
#BileDuctCancer #cholangiocarcinoma #rarecancer #AMMF #LiverTwitter

[BSI Tumour Immunology @BSI_TumourImm]

Tumour immunologists get ready! 🚨

We are excited to announce our next meeting in Birmingham UK (14/15th March 2024) exploring the role of the immune system in the tumour microenvironment! 🥳

Registration and details soon! 🤩

https://t.co/69KSMI5YpY

#TumourMicroenvironment24

[Jonathan Fallowfield @JAFallowfield]

Great opportunity for future collaborations in #MASLD #NAFLD #livertwitter here is the link to our paper in @NatureMedicine https://t.co/pawmmVbKOS

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@nekisa_zakeri @wellcometrust @unibirm_MDS @Bham_HPB_LTx @BirminghamLiver @HCC_HUNTER Amazing! Many congrats Nekisa👏🏽

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@UnaRastovic Many congrats Una! 👏🏽👏🏽

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@CRUKresearch @Cambridge_Uni @aitken_lab Amazing! Huge congrats Sarah! 👏🏽👏🏽

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@ShivanSivakumar @unibirmingham @uhbtrust @UHBCancer Many congrats Shiv! 👏🏽👏🏽

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@DrElePalma @Inst_of_Hep Many congrats Ele! Thrilled for you👏🏽

[BSI Congress & Events @bsicongress]

#BSI23 Congress will take place on 4-7 December in Belfast 🥳

Opening with our keynote Dr Ronald Germain from @NIAIDNews @NIH & featuring 6 plenary sessions on exciting #immunology themes: https://t.co/JPoy0m7yTK

🔜 Abstract submission & registration will open soon!

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@ljpally19 Many congrats Laura! Very well deserved 👏🏽👏🏽

[Sophia Karagiannis @SophiaKaragiann]

Our manuscript entitled "B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma” is published in Nature Communications. Congratulations to Silvia Crescioli and our fantastic colleagues! https://t.co/S0ZBczavse

[Maini Lab UCL @maini_lab]

Interested in harnessing tissue #Tcells to fight #viruses and #cancer? Come and join our dynamic team at @iit_UCL's newly built translational immunology institute in London.

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@onco_hannah @UniOfSurrey @OxfordOncology @Hammond_Lab Many congrats Hannah! Such an exciting time for you🤩

[Isioma Egbuniwe MBBS PhD FRCPath @drIsiEbueku]

@enjywenjy Many congratulations 👏🏽 👏🏽! So happy for you🤗